Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish

Huifang Xu; Xuxia Tang; Jingjing Chen; Ya Shi; Jun Liu; Shengya Guo; Jiali Zhou; Chunqi Li; Jing He Zhou

doi:doi:10.11648/j.ijast.20210503.15

| Peer-Reviewed

Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish

Huifang Xu, Xuxia Tang, Jingjing Chen, Ya Shi, Jun Liu, Shengya Guo, Jiali Zhou, Chunqi Li, Jing He Zhou

Published in International Journal of Animal Science and Technology (Volume 5, Issue 3)

Received: 2 September 2021 Accepted: 22 September 2021 Published: 30 September 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Tripterygium glycosides (TG) is isolated from an extensively used traditional Chinese medicine herb tripterygium roots and has been extensively used in the treatment of rheumatoid arthritis, nephrotic syndrome, hyperthyroidism and other diseases due to its anti-inflammatory and immunosuppressive effects. Hearing toxicity has been recently associated with TG use in human patients. In this study, authors assessed hearing toxicity and possible molecular toxic mechanisms of TG in a whole animal model. The maximum non-lethal concentration (MNLC) of TG on the zebrafish was 21 mg/L. TG induced zebrafish hair cell loss in a dose-dependent manner (p<0.001), and the saccular otolith size reduction when treated at MNLC (p<0.01). TG treatment resulted in sound-stimulated zebrafish movement reduction (p<0.001); and the rollover zebrafish percentages were elevated as TG treatment concentrations moved up. Following TG treatment, mRNA levels of the zebrafish hearing organ development genes eya1 and val were remarkably downregulated, and the expression of apoptosis-associated genes bax and caspase3 was significantly enhanced (p<0.05). These findings confirm the hearing toxicity of TG and suggest its toxic mechanisms probably are through suppressing hearing cell development and promoting hearing cell apoptosis. Authors recommend zebrafish assay as a quick and reliable screening test of hearing toxicity for drugs and health products.

Published in	International Journal of Animal Science and Technology (Volume 5, Issue 3)
DOI	10.11648/j.ijast.20210503.15
Page(s)	79-86
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Tripterygium glycosides, Hearing Toxicity, Hair Cell, Zebrafish

References

[1]	Arslan E, Orzan E, Santarelli R. Global problem of drug-induced hearing loss. Ann N Y Acad Sci 1999; 884 (1): 1-14.
[2]	Buck LM, Winter MJ, Redfern WS, Whitfield TT. Ototoxin-induced cellular damage in neuromasts disrupts lateral line function in larval zebrafish. Hearing Res 2012; 284 (1-2): 67-81.
[3]	Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 2008; 9 (2): 178-90.
[4]	Rah YC, Yoo MH, Choi J, Park S, Park HC, Oh KH, et al. In vivo assessment of hair cell damage and developmental toxicity caused by gestational caffeine exposure using zebrafish (Danio rerio) models. Neurotoxicol Teratol. 2017; 64: 1-7.
[5]	Anon. FDA Guidance for Industry: M3 (R2) nonclinical safety studies for the conduct of human clinical trials and marketing authorization of pharmaceuticals: US Department of Health and Human Services Food and Drug Administration CDER CBER 2010.
[6]	ICH. ICH S7A: Safety pharmacology studies for human pharmaceuticals 2005.
[7]	Ou H, Simon JA, Rubel EW, Raible DW. Screening for chemicals that affect hair cell death and survival in the zebrafish lateral line. Hearing Res 2012; 288 (1-2): 58-66.
[8]	Bu X, Fan J, Hu X, Bi X, Peng B, Zhang D. Norwegian scabies in a patient treated with Tripterygium glycoside for rheumatoid arthritis. An Bras Dermatol 2017; 92 (4): 556-8.
[9]	Canter PH, Lee HS, Ernst E. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 2006; 13 (5): 371-7.
[10]	Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 2001; 28 (10): 2160-7.
[11]	Patavino T, Brady DM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev 2001; 6 (5): 460-71.
[12]	Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Tori M, et al. Immunosuppressive terpenoids from extracts of Tripterygium wilfordii. Tetrahedron 2001; 57 (40): 8413-24.
[13]	Wan YG, Zhao Q, Sun W, Zhang HL, Li M, Wei QX, et al. Contrasting dose-effects of multi-glycoside of Tripterygium wilfordii HOOK. f. on glomerular inflammation and hepatic damage in two types of anti-Thy1.1 glomerulonephritis. J Pharmacol Sci 2012; 118 (4): 433-46.
[14]	Zhu B, Wang Y, Jardine M, Jun M, Lv J-C, Cass A, et al. Tripterygium Preparations for the Treatment of CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2013; 62 (3): 515-30.
[15]	Pyatt DW, Yang Y, Mehos B, Le A, Stillman W, Irons RD. Hematotoxicity of the chinese herbal medicine Tripterygium wilfordii hook f in CD34-positive human bone marrow cells. Mol Pharmacol 2000; 57 (3): 512-8.
[16]	Wang J, Wang C, Wu J, Li Y, Hu X, Wen J, et al. Oral microemulsion based delivery system for reducing reproductive and kidney toxicity of Tripterygium glycosides. J Microencapsul 2019; 36 (6): 523-34.
[17]	Yun, N R. and Gan, J. S. Clinical side effect summary of ripterygium roots and preparation formulations. Tianjin Pharmaceuticals 2012; 24, 18-23.
[18]	Popper A N. Hair cell heterogeneity and ultrasonic hearing: Recent advances in understanding fish hearing. Philos Trans R Soc Lond B Biol Sci 2000; 355 (1401): 1277-1280.
[19]	Whitfield TT, Riley BB, Chiang MY, Phillips B. Development of the zebrafish inner ear. Dev Dynam 2002; 223 (4): 427-58.
[20]	Fay. Comparative Hearing: Fish and Amphibians. Springer Berlin 1999; 11 (19): 1549-53.
[21]	Haddon C, Lewis J. Early ear development in the embryo of the zebrafish, Danio rerio. J Comp Neurol 1996; 365 (1): 113-28.
[22]	Owens KN, Cunningham DE, MacDonald G, Rubel EW, Raible DW, Pujol R. Ultrastructural analysis of aminoglycoside-induced hair cell death in the zebrafish lateral line reveals an early mitochondrial response. J Comp Neurol 2007; 502 (4): 522-43.
[23]	Abbas L, Whitfield TT. The zebrafish inner ear. Fish Physiol Biochem 2010; 29 (10): 123-71.
[24]	Ton C, Parng C. The use of zebrafish for assessing ototoxic and otoprotective agents. Hearing Res 2005; 208 (1-2): 79-88.
[25]	Guo S Y, Zhang Y, Zhu X Y, et al. Developmental neurotoxicity and toxic mechanisms induced by olaquindox in zebrafish. J Appl Toxicol 2020, 41 (4): 549-560.
[26]	Balak K J, Corwin J T, Jones J E. Regenerated hair cells can originate from supporting cell progeny: Evidence from phototoxicity and laser ablation experiments in the lateral line system. J Neurosci 1990, 10 (8): 2502-2512.
[27]	Zeddies DG, Fay RR. Development of the acoustically evoked behavioral response in zebrafish to pure tones. J Exp Biol 2005; 208 (Pt 7): 1363-72.
[28]	Zhao Z, Tong JW, Zhang JP, You XF, Hu CQ. Zebrafish model for the study on drug ototoxicity of aminoglycoside antibiotics. Acta Pharm Sin 2011; 46 (8): 928-35.
[29]	Sharif F, Steenbergen PJ, Metz JR, Champagne DL. Long-lasting effects of dexamethasone on immune cells and wound healing in the zebrafish. Wound Repair Regen 2015; 23 (6): 855-65.
[30]	Zhou J, Guo S Y, Zhang Y, et al. Human prokinetic drugs promote gastrointestinal motility in zebrafish. Neurogastroent Motil 2014, 26 (4): 589-595.
[31]	Hill AJ, Teraoka H, Heideman W, Peterson RE. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005; 86 (1): 6-19.
[32]	McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Discov Today 2008; 13 (9-10): 394-401.
[33]	Bever MM, Fekete DM. Atlas of the developing inner ear in zebrafish. Dev Dynam 2002; 223 (4): 536-43.
[34]	Ghysen A, Dambly-Chaudière C. Development of the zebrafish lateral line. Current Opinion Neurobiol 2004; 14 (1): 67-73.
[35]	Metcalfe W. Organisation and development of the zebrafish posterior lateral line [M]. New York: Springer-Verlag 1989: 147–159.
[36]	Metcalfe WK, Kimmel CB, Schabtach E. Anatomy of the posterior lateral line system in young larvae of the zebrafish. J Comp Neurol 1985; 233 (3): 377-89.
[37]	Raible DW, Kruse GJ. Organization of the lateral line system in embryonic zebrafish. J Comp Neurol 2000; 421 (2): 189-98.
[38]	Yoo M H, Rah Y C, Choi J, et al. Embryotoxicity and hair cell toxicity of silver nanoparticles in zebrafish embryos. Int J Pediatr Otorhinolaryngol 2016, 83: 168-174.
[39]	Fay RR, Popper AN. Acoustic stimulation of the ear of the goldfish (Carassius auratus). J Exp Biol 1974; 61 (1): 243-60.
[40]	Pisam M, Jammet C, Laurent D. First steps of otolith formation of the zebrafish: role of glycogen? Cell Tissue Res 2002; 310 (2): 163-8.
[41]	Furness DN. Molecular basis of hair cell loss. Cell Tissue Res 2015; 361 (1): 387-99.
[42]	Lenz DR, Avraham KB. Hereditary hearing loss: from human mutation to mechanism. Hearing Res 2011; 281 (1-2): 3-10.
[43]	Nelson EG, Hinojosa R. Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature. Laryngoscope 2006; 116: 1-12.
[44]	Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005; 10 (19): 1313-21.
[45]	Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec 2012; 295 (11): 1837-50.
[46]	Tees RC. Effects of early auditory restriction in the rat on adult pattern discrimination. J Comp Physiol Psychol 1967; 63 (3): 389-93.
[47]	Kozlowski DJ, Whitfield TT, Hukriede NA, Lam WK, Weinberg ES. The zebrafish dog-eared mutation disrupts eya1, a gene required for cell survival and differentiation in the inner ear and lateral line. Dev Biol 2005; 277 (1): 27-41.
[48]	Bonini NM, Leiserson WM, Benzer S. The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 1993; 72 (3): 379-95.
[49]	Xu PX, Adams J, Peters H, Brown MC, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999; 23 (1): 113-7.
[50]	Kwak SJ, Phillips BT, Heck R, Riley BB. An expanded domain of fgf3 expression in the hindbrain of zebrafish valentino mutants results in mis-patterning of the otic vesicle. Development 2002; 129 (22): 5279-87.
[51]	Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003; 39 (11): 615-47.
[52]	Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Bio 2010; 11 (9): 621-32.
[53]	Van Delft MF, Huang DC. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 2006; 16 (2): 203-13.
[54]	Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278 (5345): 1966-8.
[55]	Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999; 274 (30): 21155-61.
[56]	Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997; 278 (5336): 294-8.
[57]	Lazebnik Y A, Kaufmann S H, Desnoyers S, et al. Cleavage of poly(adp-ribose) polymerase by a proteinase with properties like ice. Nature 1994, 371 (6495): 346-347.

Cite This Article

Plain Text BibTeX RIS

APA Style

Huifang Xu, Xuxia Tang, Jingjing Chen, Ya Shi, Jun Liu, et al. (2021). Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. International Journal of Animal Science and Technology, 5(3), 79-86. https://doi.org/10.11648/j.ijast.20210503.15

Copy | Download

ACS Style

Huifang Xu; Xuxia Tang; Jingjing Chen; Ya Shi; Jun Liu, et al. Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. Int. J. Anim. Sci. Technol. 2021, 5(3), 79-86. doi: 10.11648/j.ijast.20210503.15

Copy | Download

AMA Style

Huifang Xu, Xuxia Tang, Jingjing Chen, Ya Shi, Jun Liu, et al. Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. Int J Anim Sci Technol. 2021;5(3):79-86. doi: 10.11648/j.ijast.20210503.15

Copy | Download

@article{10.11648/j.ijast.20210503.15,
  author = {Huifang Xu and Xuxia Tang and Jingjing Chen and Ya Shi and Jun Liu and Shengya Guo and Jiali Zhou and Chunqi Li and Jing He Zhou},
  title = {Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish},
  journal = {International Journal of Animal Science and Technology},
  volume = {5},
  number = {3},
  pages = {79-86},
  doi = {10.11648/j.ijast.20210503.15},
  url = {https://doi.org/10.11648/j.ijast.20210503.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijast.20210503.15},
  abstract = {Tripterygium glycosides (TG) is isolated from an extensively used traditional Chinese medicine herb tripterygium roots and has been extensively used in the treatment of rheumatoid arthritis, nephrotic syndrome, hyperthyroidism and other diseases due to its anti-inflammatory and immunosuppressive effects. Hearing toxicity has been recently associated with TG use in human patients. In this study, authors assessed hearing toxicity and possible molecular toxic mechanisms of TG in a whole animal model. The maximum non-lethal concentration (MNLC) of TG on the zebrafish was 21 mg/L. TG induced zebrafish hair cell loss in a dose-dependent manner (pTG treatment resulted in sound-stimulated zebrafish movement reduction (pTG treatment concentrations moved up. Following TG treatment, mRNA levels of the zebrafish hearing organ development genes eya1 and val were remarkably downregulated, and the expression of apoptosis-associated genes bax and caspase3 was significantly enhanced (pTG and suggest its toxic mechanisms probably are through suppressing hearing cell development and promoting hearing cell apoptosis. Authors recommend zebrafish assay as a quick and reliable screening test of hearing toxicity for drugs and health products.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish
AU  - Huifang Xu
AU  - Xuxia Tang
AU  - Jingjing Chen
AU  - Ya Shi
AU  - Jun Liu
AU  - Shengya Guo
AU  - Jiali Zhou
AU  - Chunqi Li
AU  - Jing He Zhou
Y1  - 2021/09/30
PY  - 2021
N1  - https://doi.org/10.11648/j.ijast.20210503.15
DO  - 10.11648/j.ijast.20210503.15
T2  - International Journal of Animal Science and Technology
JF  - International Journal of Animal Science and Technology
JO  - International Journal of Animal Science and Technology
SP  - 79
EP  - 86
PB  - Science Publishing Group
SN  - 2640-1312
UR  - https://doi.org/10.11648/j.ijast.20210503.15
AB  - Tripterygium glycosides (TG) is isolated from an extensively used traditional Chinese medicine herb tripterygium roots and has been extensively used in the treatment of rheumatoid arthritis, nephrotic syndrome, hyperthyroidism and other diseases due to its anti-inflammatory and immunosuppressive effects. Hearing toxicity has been recently associated with TG use in human patients. In this study, authors assessed hearing toxicity and possible molecular toxic mechanisms of TG in a whole animal model. The maximum non-lethal concentration (MNLC) of TG on the zebrafish was 21 mg/L. TG induced zebrafish hair cell loss in a dose-dependent manner (pTG treatment resulted in sound-stimulated zebrafish movement reduction (pTG treatment concentrations moved up. Following TG treatment, mRNA levels of the zebrafish hearing organ development genes eya1 and val were remarkably downregulated, and the expression of apoptosis-associated genes bax and caspase3 was significantly enhanced (pTG and suggest its toxic mechanisms probably are through suppressing hearing cell development and promoting hearing cell apoptosis. Authors recommend zebrafish assay as a quick and reliable screening test of hearing toxicity for drugs and health products.
VL  - 5
IS  - 3
ER  -

Copy | Download

Author Information

Huifang Xu

Otolaryngology Department, Zhejiang Provincial Hospital of Traditional Chinese Medical, Hangzhou, China
Xuxia Tang

Otolaryngology Department, Zhejiang Provincial Hospital of Traditional Chinese Medical, Hangzhou, China
Jingjing Chen

Otolaryngology Department, Zhejiang Provincial Hospital of Traditional Chinese Medical, Hangzhou, China
Ya Shi

Otolaryngology Department, Zhejiang Provincial Hospital of Traditional Chinese Medical, Hangzhou, China
Jun Liu

Otolaryngology Department, Zhejiang Provincial Hospital of Traditional Chinese Medical, Hangzhou, China
Shengya Guo

Hunter Biotechnology, Hangzhou, China
Jiali Zhou

Hunter Biotechnology, Hangzhou, China
Chunqi Li

Hunter Biotechnology, Hangzhou, China
Jing He Zhou

Department of Plastic Surgery, Affiliated Hangzhou First People’s Hospital Zhejiang University School of Medicine, Hangzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Huifang Xu, Xuxia Tang, Jingjing Chen, Ya Shi, Jun Liu, et al. (2021). Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. International Journal of Animal Science and Technology, 5(3), 79-86. https://doi.org/10.11648/j.ijast.20210503.15

Copy | Download

ACS Style

Huifang Xu; Xuxia Tang; Jingjing Chen; Ya Shi; Jun Liu, et al. Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. Int. J. Anim. Sci. Technol. 2021, 5(3), 79-86. doi: 10.11648/j.ijast.20210503.15

Copy | Download

AMA Style

Huifang Xu, Xuxia Tang, Jingjing Chen, Ya Shi, Jun Liu, et al. Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish. Int J Anim Sci Technol. 2021;5(3):79-86. doi: 10.11648/j.ijast.20210503.15

Copy | Download

@article{10.11648/j.ijast.20210503.15,
  author = {Huifang Xu and Xuxia Tang and Jingjing Chen and Ya Shi and Jun Liu and Shengya Guo and Jiali Zhou and Chunqi Li and Jing He Zhou},
  title = {Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish},
  journal = {International Journal of Animal Science and Technology},
  volume = {5},
  number = {3},
  pages = {79-86},
  doi = {10.11648/j.ijast.20210503.15},
  url = {https://doi.org/10.11648/j.ijast.20210503.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijast.20210503.15},
  abstract = {Tripterygium glycosides (TG) is isolated from an extensively used traditional Chinese medicine herb tripterygium roots and has been extensively used in the treatment of rheumatoid arthritis, nephrotic syndrome, hyperthyroidism and other diseases due to its anti-inflammatory and immunosuppressive effects. Hearing toxicity has been recently associated with TG use in human patients. In this study, authors assessed hearing toxicity and possible molecular toxic mechanisms of TG in a whole animal model. The maximum non-lethal concentration (MNLC) of TG on the zebrafish was 21 mg/L. TG induced zebrafish hair cell loss in a dose-dependent manner (pTG treatment resulted in sound-stimulated zebrafish movement reduction (pTG treatment concentrations moved up. Following TG treatment, mRNA levels of the zebrafish hearing organ development genes eya1 and val were remarkably downregulated, and the expression of apoptosis-associated genes bax and caspase3 was significantly enhanced (pTG and suggest its toxic mechanisms probably are through suppressing hearing cell development and promoting hearing cell apoptosis. Authors recommend zebrafish assay as a quick and reliable screening test of hearing toxicity for drugs and health products.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Hearing Toxicity Induced by Tripterygium Glycosides in Zebrafish
AU  - Huifang Xu
AU  - Xuxia Tang
AU  - Jingjing Chen
AU  - Ya Shi
AU  - Jun Liu
AU  - Shengya Guo
AU  - Jiali Zhou
AU  - Chunqi Li
AU  - Jing He Zhou
Y1  - 2021/09/30
PY  - 2021
N1  - https://doi.org/10.11648/j.ijast.20210503.15
DO  - 10.11648/j.ijast.20210503.15
T2  - International Journal of Animal Science and Technology
JF  - International Journal of Animal Science and Technology
JO  - International Journal of Animal Science and Technology
SP  - 79
EP  - 86
PB  - Science Publishing Group
SN  - 2640-1312
UR  - https://doi.org/10.11648/j.ijast.20210503.15
AB  - Tripterygium glycosides (TG) is isolated from an extensively used traditional Chinese medicine herb tripterygium roots and has been extensively used in the treatment of rheumatoid arthritis, nephrotic syndrome, hyperthyroidism and other diseases due to its anti-inflammatory and immunosuppressive effects. Hearing toxicity has been recently associated with TG use in human patients. In this study, authors assessed hearing toxicity and possible molecular toxic mechanisms of TG in a whole animal model. The maximum non-lethal concentration (MNLC) of TG on the zebrafish was 21 mg/L. TG induced zebrafish hair cell loss in a dose-dependent manner (pTG treatment resulted in sound-stimulated zebrafish movement reduction (pTG treatment concentrations moved up. Following TG treatment, mRNA levels of the zebrafish hearing organ development genes eya1 and val were remarkably downregulated, and the expression of apoptosis-associated genes bax and caspase3 was significantly enhanced (pTG and suggest its toxic mechanisms probably are through suppressing hearing cell development and promoting hearing cell apoptosis. Authors recommend zebrafish assay as a quick and reliable screening test of hearing toxicity for drugs and health products.
VL  - 5
IS  - 3
ER  -

Copy | Download